Modeling core metabolism in cancer cells: Surveying the topology underlying the warburg effect

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Resendis Antonio, Osbaldo ^a   Checa, Alberto ^a   Encarnación, Sergio ^a  

^a INSTITUTO DE CIENCIAS FÍSICAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE; LACTATE DEHYDROGENASE; PENTOSE PHOSPHATE; PYRUVATE DEHYDROGENASE;

AMINOLYSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER MODEL; CELL KINETICS; CELL METABOLISM; CITRIC ACID CYCLE; COMPUTER MODEL; COMPUTER SIMULATION; CONTROLLED STUDY; ENZYME MECHANISM; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GLYCOLYSIS; HELA CELL; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; METABOLIC REGULATION; MOLECULAR INTERACTION; OXIDATIVE PHOSPHORYLATION; PHENOTYPIC VARIATION; REPRODUCIBILITY; SIGNAL TRANSDUCTION; TUMOR GENE; BIOLOGICAL MODEL; BIOLOGY; CELL PROLIFERATION; METABOLISM; NEOPLASM; PATHOLOGY; PENTOSE PHOSPHATE CYCLE; PHENOTYPE;

CELL PROLIFERATION; CITRIC ACID CYCLE; COMPUTATIONAL BIOLOGY; GLYCOLYSIS; HELA CELLS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; OXIDATIVE PHOSPHORYLATION; PENTOSE PHOSPHATE PATHWAY; PHENOTYPE;

EID: 77957859044     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012383     Document Type: Article

References (42)

1. Weinberg RA (2007) The biology of Cancer. Garland Sciences, Taylor & Francis Group, LLC.
2. Hsu PP, Sabatini DM (2008) Cancer cell metabolism: Warburg and beyond. Cell 134: 703-707.
3. Shaw RJ (2006) Glucose metabolism and cancer. Curr Opin Cell Biol 18: 598-608.
4. Kreeger PK, Lauffenburger DA (2009) Cancer Systems Biology: A Network Modeling Perspective. Carcinogenesis.
5. Wolkenhauer O, Auffray C, Baltrusch S, Bluthgen N, Byrne H, et al. Systems biologists seek fuller integration of systems biology approaches in new cancer research programs. Cancer Res 70: 12-13.
6. Cascante M, Boros LG, Comin-Anduix B, de Atauri P, Centelles JJ, et al. (2002) Metabolic control analysis in drug discovery and disease. Nat Biotechnol 20: 243-249.
7. Warburg O (1956) On the origin of cancer cells. Science 123: 309-314.
8. DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, et al. (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A 104: 19345-19350.
9. Vousden KH, Ryan KM (2009) p53 and metabolism. Nat Rev Cancer 9: 691-700.
10. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, et al. (2006) p53 regulates mitochondrial respiration. Science 312: 1650-1653.
11. Palsson B (2009) Metabolic systems biology. FEBS Lett.
12. Resendis-Antonio O, Reed JL, Encarnacion S, Collado-Vides J, Palsson BO (2007) Metabolic reconstruction and modeling of nitrogen fixation in Rhizobium etli. PLoS Comput Biol 3: 1887-1895.
13. Feist AM, Herrgard MJ, Thiele I, Reed JL, Palsson BO (2009) Reconstruction of biochemical networks in microorganisms. Nat Rev Microbiol 7: 129-143.
14. Feist AM, Palsson BO (2008) The growing scope of applications of genome-scale metabolic reconstructions using Escherichia coli. Nat Biotechnol 26: 659-667.
15. Zhang Y, Thiele I, Weekes D, Li Z, Jaroszewski L, et al. (2009) Three-dimensional structural view of the central metabolic network of Thermotoga maritima. Science 325: 1544-1549.
16. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033.
17. Garber K (2006) Energy deregulation: licensing tumors to grow. Science 312: 1158-1159.
18. Bachtiary B, Boutros PC, Pintilie M, Shi W, Bastianutto C, et al. (2006) Gene expression profiling in cervical cancer: an exploration of intratumor heterogeneity. Clin Cancer Res 12: 5632-5640.
19. Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891-899.
20. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70.
21. Varma A, Palsson B (1994) Stoichiometric Flux Balance Models Quantitatively predict growth and metabolic Byproduct secretion in Wild-type Escherichia coli W3110. Applied and Environmental Microbiology 60: 3724-3731.
22. Palsson B (2006) Systems Biology: Properties of Reconstructed Networks. New York: Cambridge University Press.
23. Price ND, Reed JL, Palsson BO (2004) Genome-scale models of microbial cells: evaluating the consequences of constraints. Nat Rev Microbiol 2: 886-897.
24. Thiele I, Palsson BOA protocol for generating a high-quality genome-scale metabolic reconstruction. Nat Protoc 5: 93-121.
25. Deberardinis RJ, Sayed N, Ditsworth D, Thompson CB (2008) Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 18: 54-61.
26. Jones RG, Thompson CB (2009) Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev 23: 537-548.
27. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, et al. (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452: 230-233.
28. Becker SA, Feist AM, Mo ML, Hannum G, Palsson BO, et al. (2007) Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox. Nat Protoc 2: 727-738.
29. Xu RH, Pelicano H, Zhou Y, Carew JS, Feng L, et al. (2005) Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res 65: 613-621.
30. Fantin VR, St-Pierre J, Leder P (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9: 425-434.
31. Dang CV, Semenza GL (1999) Oncogenic alterations of metabolism. Trends Biochem Sci 24: 68-72.
32. McFate T, Mohyeldin A, Lu H, Thakar J, Henriques J, et al. (2008) Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells. J Biol Chem 283: 22700-22708.
33. Gottlieb E, Tomlinson IP (2005) Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer 5: 857-866.
34. Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, et al. (2005) ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8: 311-321.
35. Ramos-Montoya A, Lee WN, Bassilian S, Lim S, Trebukhina RV, et al. (2006) Pentose phosphate cycle oxidative and nonoxidative balance: A new vulnerable target for overcoming drug resistance in cancer. Int J Cancer 119: 2733-2741.
36. Duarte NC, Becker SA, Jamshidi N, Thiele I, Mo ML, et al. (2007) Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci U S A 104: 1777-1782.
37. Covert MW, Knight EM, Reed JL, Herrgard MJ, Palsson BO (2004) Integrating high-throughput and computational data elucidates bacterial networks. Nature 429: 92-96.
38. Covert MW, Palsson BO (2002) Transcriptional regulation in constraints-based metabolic models of Escherichia coli. J Biol Chem 277: 28058-28064.
39. Kitano H (2004) Biological robustness. Nat Rev Genet 5: 826-837.
40. Resendis-Antonio O (2009) Filling kinetic gaps: dynamic modeling of metabolism where detailed kinetic information is lacking. PLoS One 4: e4967.
41. Price ND, Schellenberger J, Palsson BO (2004) Uniform sampling of steady-state flux spaces: means to design experiments and to interpret enzymopathies. Biophys J 87: 2172-2186.
42. Wiback SJ, Famili I, Greenberg HJ, Palsson BO (2004) Monte Carlo sampling can be used to determine the size and shape of the steady-state flux space. J Theor Biol 228: 437-447.